| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 26.455 | 66.008 | 56.999 | - | 9.218 | 43.185 | 29.703 | 4.181 |
| Total Income - EUR | - | - | 26.455 | 66.008 | 56.999 | - | 9.218 | 43.185 | 29.703 | 4.181 |
| Total Expenses - EUR | - | - | 1.195 | 1.631 | 2.148 | - | 578 | 577 | 346 | 72 |
| Gross Profit/Loss - EUR | - | - | 25.260 | 64.377 | 54.851 | - | 8.640 | 42.608 | 29.357 | 4.110 |
| Net Profit/Loss - EUR | - | - | 24.466 | 62.637 | 53.141 | - | 8.363 | 41.312 | 24.660 | 3.465 |
| Employees | - | - | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Aria Medical Research S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 91 | 0 | 0 | - | 0 | 0 | 0 | 0 |
| Current Assets | - | - | 25.160 | 63.019 | 109.506 | - | 12.449 | 51.374 | 54.323 | 31.283 |
| Inventories | - | - | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 |
| Receivables | - | - | 0 | 8 | 0 | - | 700 | 1.164 | 53.002 | 30.005 |
| Cash | - | - | 25.160 | 63.011 | 109.506 | - | 11.749 | 50.210 | 1.321 | 1.278 |
| Shareholders Funds | - | - | 24.510 | 62.689 | 53.192 | - | 8.842 | 50.182 | 33.502 | 12.258 |
| Social Capital | - | - | 44 | 43 | 42 | - | 40 | 41 | 40 | 40 |
| Debts | - | - | 741 | 331 | 56.315 | - | 3.607 | 1.192 | 20.821 | 19.025 |
| Income in Advance | - | - | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7219 - 7219" | |||||||||
| CAEN Financial Year |
7219
|
|||||||||
Comments - Aria Medical Research S.r.l.